ES2061406A1 - Nuevos derivados de la 2-(quinolina) con actividad farmacologica. - Google Patents

Nuevos derivados de la 2-(quinolina) con actividad farmacologica.

Info

Publication number
ES2061406A1
ES2061406A1 ES09300982A ES9300982A ES2061406A1 ES 2061406 A1 ES2061406 A1 ES 2061406A1 ES 09300982 A ES09300982 A ES 09300982A ES 9300982 A ES9300982 A ES 9300982A ES 2061406 A1 ES2061406 A1 ES 2061406A1
Authority
ES
Spain
Prior art keywords
quinoline derivatives
pharmacological activity
new quinoline
new
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09300982A
Other languages
English (en)
Other versions
ES2061406B1 (es
Inventor
Elena Carceller
Nuria Recasens
Carmen Almansa
Javier Bartroli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noucor Health SA
Original Assignee
J Uriach y Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J Uriach y Cia SA filed Critical J Uriach y Cia SA
Priority to ES09300982A priority Critical patent/ES2061406B1/es
Priority to CA002123057A priority patent/CA2123057A1/en
Priority to EP94107134A priority patent/EP0624588A1/en
Priority to JP6119520A priority patent/JPH072868A/ja
Publication of ES2061406A1 publication Critical patent/ES2061406A1/es
Application granted granted Critical
Publication of ES2061406B1 publication Critical patent/ES2061406B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

NUEVOS DERIVADOS DE LA 2-(QUINOLINA) CON ACTIVIDAD FARMACOLOGICA. NUEVOS DERIVADOS DE LA 2-(QUINOLINA) DE FORMULA I, EN DONDE N ES 0 O 1, Y SUS SALES Y SOLVATOS. LA PRESENTE INVENCION DESCRIBE TAMBIEN PROCEDIMIENTOS PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. DICHOS COMPUESTOS SON ANTAGONISTAS DUALES DEL PAF Y LA 5-LIPOXIGENASA, Y POR LO TANTO, SON UTILES EN EL TRATAMIENTO Y/O PREVENCION DE LAS ENFERMEDADES DONDE EL PAF Y/O LA 5-LIPOXIGENASA SE HALLAN IMPLICADOS.
ES09300982A 1993-05-07 1993-05-07 Nuevos derivados de la 2-(quinolina) con actividad farmacologica. Expired - Fee Related ES2061406B1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES09300982A ES2061406B1 (es) 1993-05-07 1993-05-07 Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
CA002123057A CA2123057A1 (en) 1993-05-07 1994-05-06 Quinoline derivatives with pharmacological activity
EP94107134A EP0624588A1 (en) 1993-05-07 1994-05-06 New quinoline derivatives with pharmacological activity
JP6119520A JPH072868A (ja) 1993-05-07 1994-05-09 薬理活性を有する新規なキノリン誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09300982A ES2061406B1 (es) 1993-05-07 1993-05-07 Nuevos derivados de la 2-(quinolina) con actividad farmacologica.

Publications (2)

Publication Number Publication Date
ES2061406A1 true ES2061406A1 (es) 1994-12-01
ES2061406B1 ES2061406B1 (es) 1995-06-01

Family

ID=8281737

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09300982A Expired - Fee Related ES2061406B1 (es) 1993-05-07 1993-05-07 Nuevos derivados de la 2-(quinolina) con actividad farmacologica.

Country Status (4)

Country Link
EP (1) EP0624588A1 (es)
JP (1) JPH072868A (es)
CA (1) CA2123057A1 (es)
ES (1) ES2061406B1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294139A1 (en) * 1997-06-25 1998-12-30 Nikken Chemicals Co., Ltd. Triazolo-1,4-diazepine compounds and medicinal composition containing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339416A1 (de) * 1988-04-29 1989-11-02 Bayer Ag Gegebenenfalls alpha-substituierte 4-(Chinolin-2-yl-methoxy)phenylessigsäuren und -ester
EP0367110A1 (en) * 1988-10-31 1990-05-09 Eisai Co., Ltd. 1,4-diazepine derivative and its pharmaceutical use
ES2019840A6 (es) * 1989-05-13 1991-07-01 Scras Procedimiento para preparar nuevos derivados de tieno-triazolo-diazepina.
EP0481891A2 (en) * 1990-10-16 1992-04-22 Terumo Kabushiki Kaisha Phenoxyacetic acid compounds, method for production thereof, and pharmaceutical preparations containing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732978A (en) * 1985-10-03 1988-03-22 American Home Products Corporation Novel substituted naphthyloxymethyl quinoline derivatives as anti-inflammatory and antiallergy agents
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
GB8907256D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-asthmatic anti-allergic and gastro-intestinal protectors
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
JP2971901B2 (ja) * 1990-03-15 1999-11-08 エーザイ株式会社 トリアゾロ―１，４―ジアゼピン系化合物
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4107521A1 (de) * 1991-03-08 1992-09-10 Boehringer Ingelheim Kg Neue acylaminosubstituierte hetrazepine
DE4125270A1 (de) * 1991-07-31 1993-02-04 Bayer Ag Chinolin-2-yl-methoxybenzylhydroxyharnstoffe
EP0656004A1 (en) * 1992-08-20 1995-06-07 Cytomed, Inc. Dual functional anti-inflammatory and immunosuppressive agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339416A1 (de) * 1988-04-29 1989-11-02 Bayer Ag Gegebenenfalls alpha-substituierte 4-(Chinolin-2-yl-methoxy)phenylessigsäuren und -ester
EP0367110A1 (en) * 1988-10-31 1990-05-09 Eisai Co., Ltd. 1,4-diazepine derivative and its pharmaceutical use
ES2019840A6 (es) * 1989-05-13 1991-07-01 Scras Procedimiento para preparar nuevos derivados de tieno-triazolo-diazepina.
EP0481891A2 (en) * 1990-10-16 1992-04-22 Terumo Kabushiki Kaisha Phenoxyacetic acid compounds, method for production thereof, and pharmaceutical preparations containing same

Also Published As

Publication number Publication date
JPH072868A (ja) 1995-01-06
ES2061406B1 (es) 1995-06-01
CA2123057A1 (en) 1994-11-08
EP0624588A1 (en) 1994-11-17

Similar Documents

Publication Publication Date Title
ES2062943A1 (es) Nuevos derivados de la (2-metil-3-piridil) cianometlpiperazinas.
ES2070660A1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
EP0703902A4 (es)
DE3571320D1 (en) N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
ES2130930A1 (es) Recubrimientos y materiales de registro estabilizados con absorbentes de ultravioleta de benzotriazol.
ES8205771A1 (es) Un procedimiento para la obtencion de un derivado acilado sustituido de acido octahidro-1h-indol-2-carboxilico
ATE157978T1 (de) Substituierte kondensierte pyrazolverbindungen und ihre verwendung als herbizide
ES8604128A1 (es) Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida
ES8802148A1 (es) Procedimiento para preparar derivados de acido quinoloncarboxilico
ES8606330A1 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
ES8606283A1 (es) Procedimiento para preparar derivados de acidos quinolon- carboxilicos
TW324009B (en) Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor
ES8700242A1 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
ES8504731A1 (es) Un procedimiento para preparar antra 1,9-cd-7pirazol-6(2h)-onas
IE862062L (en) Androst-5-en-17-ones
AU7819187A (en) New phenyl, pyrrolidin-2-yl substituted 5-ring heterocycles having antiphycsotic properties
ES2061406A1 (es) Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
ES8609302A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas
ES2132245T3 (es) Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht.
ES2088822A1 (es) Nuevos derivados antraquinonicos con actividad antitumoral y sus aplicaciones.
GB2182935B (en) Quinoline derivatives
EP0574271A3 (es)
IE880306L (en) Pyridopyrroloquinolines and intermediates thereof
ES8500955A1 (es) Procedimiento para la preparacion de furobenzoisoxazoles.
ES8601917A1 (es) Procedimiento para producir 4,5-dihidro-6-vinil-3(2h)-piri- dazinonas y 6-vinil-3(2h)-piridazinonas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020304